Cannabis Valuation Techniques: 2026 Update on Rescheduling, Banking Reform and Market Challenges
The cannabis industry is entering a transformative phase following President Donald Trump’s December 18, 2025, executive order directing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act. This move signals a major shift in federal policy, creating significant opportunities for operators and investors while introducing new complexities. Rescheduling has…
